by GlobeNewswireCanada | Nov 10, 2015 | Globe Newswire Canada
VANCOUVER, British Columbia, Nov. 10, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...
by GlobeNewsWire | Nov 10, 2015 | Globe Newswire
VANCOUVER, British Columbia, Nov. 10, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology,...
by GlobeNewswireCanada | Sep 16, 2015 | Globe Newswire Canada
VANCOUVER, British Columbia, Sept. 16, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and...
by GlobeNewswireCanada | Sep 9, 2015 | Globe Newswire Canada
VANCOUVER, British Columbia, Sept. 9, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and...
by GlobeNewswireCanada | Sep 8, 2015 | Globe Newswire Canada
VANCOUVER, British Columbia, Sept. 8, 2015 (GLOBE NEWSWIRE) — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and...